A reading off by even a small amount could cause a diabetic to inject too much insulin
For the millions who live by the rhythm of lancets and test strips, a patent filed by Apple in early 2021 gestures toward a quieter future — one where a glance at a wristwatch might replace the daily ritual of drawing blood. The technology, rooted in terahertz spectroscopy, would use electromagnetic waves to read glucose concentrations through the skin, asking nothing of the body in return. Whether this vision survives the long passage from patent to product remains an open question, but it speaks to a deeper human longing: to know what is happening inside us without being wounded in the asking.
- Millions of insulin-dependent diabetics endure multiple finger pricks daily — a painful, costly routine that many quietly abandon, often at the expense of their own health.
- Apple's patent proposes threading terahertz radiation through the wrist to detect blood sugar levels, bypassing needles entirely and potentially turning the Apple Watch into a medical lifeline.
- The stakes of getting it wrong are severe — a miscalibrated glucose reading could trigger a hypoglycemic crisis, meaning accuracy is not a refinement but a survival requirement.
- Engineering barriers loom large: fitting the necessary components into a watch-sized device without sacrificing water resistance, battery life, or affordability remains unsolved.
- Apple has been circling this problem for years, but the patent's highly conceptual language suggests the company is still translating physics into possibility, not yet into product.
Apple has filed a patent for a technology that could fundamentally change daily life for insulin-dependent diabetics — replacing the familiar sting of a lancet with a passive reading from an Apple Watch. The current monitoring routine is both physically painful and financially draining: a fingertip puncture, a costly test strip, a glucometer reading, repeated every day without end. Many patients skip readings simply because the burden accumulates, and every skipped reading is a missed opportunity to manage the disease well.
The patent describes using terahertz electromagnetic radiation — positioned between microwave and infrared on the spectrum — to perform absorption spectroscopy through the skin, detecting the presence and concentration of glucose without drawing a single drop of blood. If realized, the benefits would compound quickly: no more test strips, no more daily wounds, and likely more frequent monitoring, which tends to translate directly into better health outcomes.
Yet the obstacles are formidable. Accuracy is the most critical — even a small error in a glucose reading could lead to a dangerous insulin miscalculation and a hypoglycemic episode. Beyond precision, there are hard engineering realities: integrating the required sensors may compromise water resistance, the components may not fit the watch's current form factor, and continuous monitoring could drain the battery far faster than users tolerate.
Apple has been researching this space for years, but the patent's technical framing suggests the work remains conceptual. The same terahertz technology could one day screen for skin cancer and other conditions, and success here would reposition the Apple Watch as a genuine medical device. For now, the patent marks a serious intention — though the distance between a filing and a factory floor has humbled many promising ideas before.
Apple has filed a patent application for a technology that could transform how millions of insulin-dependent diabetics monitor their blood sugar. Instead of pricking their finger multiple times a day, drawing blood, and inserting a sample into a glucometer, they might one day simply glance at their Apple Watch.
The current process is both painful and expensive. Diabetics need accurate blood glucose readings before each meal to determine their insulin dose. A lancet punctures the fingertip. Blood goes onto a test strip—which costs money. The strip goes into a glucometer. The reading comes back. Then they do it again tomorrow, and the day after that. For many patients, the routine is burdensome enough that they skip readings, which means they skip the chance to manage their diabetes well. Apple's patent describes using terahertz electromagnetic radiation—a form of radiation that sits between microwave and infrared on the spectrum—to detect blood glucose levels without any needle at all. The technology is called absorption spectroscopy, and the idea is to send terahertz waves through the body to identify the presence and concentration of glucose in the blood.
If Apple can make it work, the payoff would be enormous. Diabetics would save money on test strips. They would eliminate the daily pain of finger pricks. They would likely check their blood sugar more often, which typically leads to better disease management and fewer complications. The Apple Watch would eventually pay for itself through savings alone.
But significant obstacles stand in the way. Accuracy is the first and most serious. A glucometer reading that is off by even a small margin could cause a diabetic to inject too much insulin, triggering a hypoglycemic episode—dangerously low blood sugar that can cause loss of consciousness. The technology Apple describes in the patent would not match the precision of hospital-grade equipment. There are also practical engineering challenges. Integrating a gas sensor into the watch requires an opening for air to flow, which could compromise the device's water resistance. The necessary components might not fit inside the watch's existing form factor without making it significantly larger and more expensive. And the power draw from continuous glucose monitoring could drain the battery much faster than users expect.
Apple has been exploring non-invasive blood glucose testing for years, according to the patent filing. Yet there is no public evidence that the company has moved from research into actual development. The patent itself—with its technical title "Terahertz Spectroscopy and Imaging In Dynamic Environments With Performance Enhancements using Ambient Sensors"—suggests the company is still in the conceptual phase, working through how the physics might translate into a wearable device.
The potential applications extend beyond diabetes management. The same terahertz technology could theoretically detect skin cancer and other dermatological conditions. For Apple, cracking non-invasive glucose monitoring would represent a major step toward positioning the Apple Watch as a genuine medical device, not just a fitness tracker. For diabetics, it would mean one fewer daily puncture wound and one fewer monthly bill. The question is whether the engineering challenges can be solved, and whether Apple will ever move this patent from the filing cabinet to the factory floor.
Notable Quotes
If the reading is off by even a small amount, the user could end up taking too much insulin and bring on a hypoglycemic or low blood sugar attack— Apple patent application
The Hearth Conversation Another angle on the story
Why does Apple care about blood glucose monitoring? It's a niche health issue.
It's not niche at all—there are roughly 37 million diabetics in the U.S. alone, and most of them need to check their blood sugar multiple times a day. That's a massive addressable market, and it's a problem people genuinely suffer with. Apple sees health as the future of the watch.
But the patent says the accuracy won't match hospital equipment. Isn't that dangerous?
Exactly. That's the core tension. If your reading is wrong by even a little, you could overdose on insulin. That's not a minor inconvenience—that's a medical emergency. Apple would need to solve that before any FDA approval, which is probably years away.
So why file the patent now if they're not close to solving it?
Patents are defensive. You file them to protect your intellectual property and to signal direction. It doesn't mean the product is coming soon. Apple has been researching this for years with no product to show for it.
What's the battery problem?
Continuous monitoring requires power. The watch already struggles to last a full day. Add a terahertz sensor running constantly, and you might get eight hours before it dies. That's not practical for a medical device.
If they solve all this, what changes?
Everything, for diabetics. No more finger pricks. No more expensive strips. Better monitoring because it doesn't hurt. And for Apple, it's a way to make the watch indispensable to a huge population with a real medical need.